AVH today announced a new board member and new chairman. I think this is material, as I have been wanting to see this change for many. many moons and am delighted it has finally come about. Hopefully they can get management to run the business more appropriately and improve their communications / financial management.
Oddly enough they didn't deem this as 'price sensitive', so no ASX announcement made. Odd because they do deem an announcement about a future announcement of results being important enough to warrant as ASX disclosure, but not changing the board or chairman..!!??
Anyway, below are the details, and happy to hear of anyone else's thoughts on this.
"...announced today the appointment to its Board of Directors (the “Board”) of Michael Tarnoff, MD, FACS, as a non-executive Director, effective August 6, 2025. Dr. Tarnoff’s appointment comes as the Company further strengthens its focus on advancing patient-centric, wound-healing technologies and expands its presence across hospitals, burn centers, and trauma care settings. “We’re thrilled to welcome Dr. Tarnoff to our Board during this pivotal phase of growth,” said Jim Corbett, Chief Executive Officer of AVITA Medical. “His leadership and expertise in clinical innovation will help us continue to scale AVITA’s impact as a therapeutic acute wound care company.
The Company’s Board also announced today that Lou Panaccio has stepped down from the position of Board Chair, and that the Board has elected Cary Vance to assume the Chair position, effective August 7, 2025."
Of course far more important will be this quarters financials. After so many bad misses and the poor capital management tomorrows result could either help rebuild some credibility, or trash it altogether. Any bets either way...!?
Add to My Watchlist
What is My Watchlist?
